I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients
Chemotherapy-nave patients with EML4-ALK rearrangement and with locally advanced or metastatic non-small cell lung cancer patients will be selected. Patients enrolled in the study will receive brigatinib 90mg for the first 7 days (D 1-7 at cycle 1) and then 180mg daily thereafter for QW4 cycles of duration (28 days …
measurable disease
adjuvant chemotherapy
heart disease
secondary malignant neoplasm of liver
aptt
- 0 views
- 19 Feb, 2024
- 15 locations
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2
Embedded within the Master Study are individual drug substudies. Investigational Drug Sub-study A: Brigatinib
ependymoma
bilateral tubal ligation
measurable disease
glioma
intrauterine device (iud)
- 0 views
- 19 Feb, 2024
- 2 locations